Bayesian meta‐analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high‐dose gantenerumab in prodromal and mild Alzheimer's disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Stefan J. Teipel, Anna G. M. Temp, Michael W. Lutz
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet